On March 21, 2013, Anthony Silverman submitted his resignation as Chief Executive Officer, President and Chairman of the Board of Oncologix Tech, Inc., effective March 21, 2013 to pursue retirement. On March 21, 2013, the Board of Directors of the company appointed Barry Griffith as Chief Executive Officer, President and Chairman of the Board. Mr. Griffith has served as a Director of the company since November 2004.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | -.--% | -.--% | -92.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-92.00% | 332K | |
+162.97% | 8.26B | |
+2.33% | 983M | |
+41.91% | 883M | |
+20.28% | 806M | |
+2.20% | 667M | |
+4.13% | 626M | |
-.--% | 600M | |
+8.61% | 529M | |
-.--% | 500M |
- Stock Market
- Equities
- OCLG Stock
- News Oncologix Tech, Inc.
- Oncologix Tech, Inc. Announces Management Changes